Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

June 2 2023 - Novartis drug helps stop breast cancer’s return in large study

Novartis drug helps stop breast cancer’s return in large study
Pfizer says antibiotic is effective against tough-to-treat infections
Medicare outlines plan to expand coverage for costly new Alzheimer’s drugs
Supreme Court vetoes efforts to limit anti-fraud law aimed at government contractors
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings

Krystal's Vyjuvek becomes first topical gene therapy with FDA nod to treat rare skin disease

Fierce Pharma

Sunday, May 21, 2023 - 10:48pm

tags:

Krystal Biotech, Vyjuvek, dystrophic epidermolysis bullosa, gene therapy, FDA

AbbVie, Genmab's lymphoma drug Epkinly snags FDA approval in heated blood cancer race

Fierce Pharma

Sunday, May 21, 2023 - 7:46pm

tags:

AbbVie, Genmab, FDA, anti-CD20, epcoritamab, diffuse large B-cell lymphoma, Epkinly

10 Trends and Statistics for Clinical Trials in 2023

Xtalks

Sunday, May 21, 2023 - 7:43pm

tags:

clinical trials, R&D, CROs

Pear Therapeutics assets sold for $6M at auction after bankruptcy

Mobihealthnews

Sunday, May 21, 2023 - 7:32pm

tags:

Pear Therapeutics, bankruptcy, digital therapeutics, Click Therapeutics, Harvest Bio, Nox Health Group, Welt, Medtech

On heels of Amgen lawsuit, FTC broadens investigation of PBMs

BioPharma Dive

Friday, May 19, 2023 - 11:38am

tags:

FTC, PBMs, Ascent Health Services, Zinc Health Services

Moderna, looking beyond vaccines, guides first mRNA protein replacement therapy past early clinical test

Fierce Biotech

Friday, May 19, 2023 - 11:33am

tags:

Moderna Therapeutics, MRNA, intracellular proteins, clinical trials, propionic acidemia

Galera earns key FDA designation for pancreatic cancer drug

Clinical Trials Arena

Friday, May 19, 2023 - 11:29am

tags:

Galera Therapeutics, pancreatic cancer, FDA, rucosopasem, orphan drugs

FDA Approves Bausch + Lomb, Novaliq Dry Eye Disease Drug

BioSpace

Friday, May 19, 2023 - 10:23am

tags:

Bausch + Lomb, Novaliq, Miebo, FDA, dry eye disease

CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South

Medical Marketing and Media

Friday, May 19, 2023 - 10:22am

tags:

CureVac, COVID-19, vaccines, Pfizer, BioNTech, patents legal

The CDC is worried about a mpox rebound and urges people to get vaccinated

NPR

Friday, May 19, 2023 - 10:20am

tags:

CDC, mpox, vaccines, Jynneos, Bavarian Nordic

How I helped Pfizer think through the ethics of Viagra 25 years ago

Stat

Friday, May 19, 2023 - 10:15am

tags:

Pfizer, Viagra, ethics, erectile dysfunction

3 Key Biotech Trends for 2023 And Beyond

Motley Fool

Friday, May 19, 2023 - 10:13am

tags:

biotech, collaboration, artificial intelligence, clinical trials, drug development

New FDA Guidance Aims to Increase Number of Children in Clinical Trials

BioSpace

Friday, May 19, 2023 - 10:11am

tags:

FDA, pediatric, clinical trials

Teva is eyeing $2.5bn in Austedo sales in 2027

Pharmaphorum

Friday, May 19, 2023 - 10:07am

tags:

Teva Pharmaceutical, Austedo

Orbital shows 2023’s venture funding scene is far from stratospheric

EP Vantage

Friday, May 19, 2023 - 10:06am

tags:

RNA, funding, venture capital, Altos Labs, CureVac, EQRx, Hasten Biopharmaceutic, Orbital Therapeutics, Sana Biotechnology, Suzhou Abogen Biosciences, TORL BioTherapeutics

FDA advisory panel backs Pfizer’s RSV vaccine, but expresses some safety concerns

Stat

Thursday, May 18, 2023 - 8:45pm

tags:

Pfizer, RSV, vaccines, FDA

Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it

CNBC

Thursday, May 18, 2023 - 8:42pm

tags:

Horizon Therapeutics, M&A, Amgen, FTC

MindMed completes 50% subject enrolment and dosing in GAD therapy trial

Clinical Trials Arena

Thursday, May 18, 2023 - 8:38pm

tags:

MindMed, clinical trials, MM-120, generalized anxiety disorder

AbbVie's Rinvoq scores its 7th FDA nod, this one for Crohn's disease

Fierce Pharma

Thursday, May 18, 2023 - 8:36pm

tags:

AbbVie, FDA, Rinvoq, Crohn's Disease, Humira

Lilly's peresolimab Phase 2a rheumatoid arthritis trial published in The New England Journal of Medicine

Drugs.com

Thursday, May 18, 2023 - 8:32pm

tags:

Eli Lilly, peresolimab, rheumatoid arthritis, clinical trials

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

Klick Health launches new healthcare venture studio

Medtech earnings reports: insights from major players' Q4 results

Key compliance issues for medtech firms transitioning to data-enabled solutions

Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

The Drug Discount Ecosystem’s “Mission Critical”

Drug Channels

Fakin' It the Modern Way

In the Pipeline

Reduction of Tau

In the Pipeline

Timeless

In the Pipeline

Drug Channels News Roundup, May 2023: 340B Shame, OptumRx vs. Humira Biosimilars, ICER on White Bagging, Hospitals vs. Taxes, and Dr. G

Drug Channels

AI and the Hard Stuff

In the Pipeline

Break Out the Purple Carrots

In the Pipeline

Five (or Maybe Six?) Reasons that the Largest PBMs Operate Group Purchasing Organizations

Drug Channels

Give Me Those Hard, Hard Numbers

In the Pipeline